经口无切口胃底折叠术在非肥胖与I度肥胖成人中的疗效与安全性:美国人群队列研究
基于TriNetX美国69家医疗机构数据的回顾性队列研究,经倾向评分1:1匹配后纳入112例非肥胖与112例I度肥胖(BMI 30-34.9)胃食管反流病成人,比较经口无切口胃底折叠术(TIF)结局。中位随访超1000天,两组术后PPI再使用、食管炎、后续手术、吞咽困难及并发症相似,肥胖组腹胀显著更低。提示TIF对I度肥胖患者安全有效,结局与非肥胖患者相当。
要点
- I度肥胖患者TIF术后PPI再使用、食管炎及再手术风险与非肥胖者相当
- 肥胖组术后1年及最长随访腹胀发生率显著低于非肥胖组
- TIF或可考虑用于BMI 30-34.9的GERD患者,但需个体化评估
核心结论
- TIF在I度肥胖(BMI 30-34.9)GERD成人中安全有效,结局与非肥胖患者相当。
研究设计与样本
- 回顾性队列研究,使用TriNetX美国研究网络,覆盖69家医疗机构至2024年12月。
- 纳入≥18岁接受TIF的GERD成人,按BMI<30与30-35分层,排除BMI>35、主要食管动力障碍及同期食管裂孔疝修补者。
- 经1:1倾向评分匹配控制年龄、性别、种族、民族、膈疝及PPI使用后,非肥胖与I度肥胖各112例。
主要发现
- 两组中位随访均超过1000天。
- 术后PPI再使用、食管炎、后续手术干预、吞咽困难及并发症在两组间相似。
- 肥胖组腹胀在1年时显著更低(aOR 0.420;95% CI 0.18-0.95),最长随访时亦更低(aOR 0.446;95% CI 0.21-0.97)。
临床怎么用
- 对于BMI 30-34.9的GERD患者,TIF可作为安全有效的治疗选择,结局与非肥胖患者相当。
- 术前应排除BMI>35、主要食管动力障碍及需同期食管裂孔疝修补的患者。
局限性
- 回顾性队列设计,可能存在未测量混杂。
- 样本量较小(匹配后每组112例),随访时间虽长但事件数有限。
- 仅代表美国TriNetX数据库人群,外推性需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transoral incisionless fundoplication (TIF) is relatively contraindicated in patients with a body mass index (BMI) > 35 kg/m2. However, the comparative efficacy of TIF in individuals with class I obesity (BMI 30-34.9) to non-obese patients remains unclear. This study aimed to evaluate the safety and efficacy of TIF in adults with class I obesity. METHODS: We conducted a retrospective cohort study using the TriNetX US Research Network, including data from 69 healthcare organizations through December 2024. Adults (≥ 18 years) with gastroesophageal reflux disease (GERD) who underwent TIF were identified using validated International Classification of Diseases, 10th Revision (ICD-10) and Current Procedural Terminology (CPT) codes. Patients were stratified by BMI (< 30 versus 30-35). Exclusion criteria in this study included the following: individuals with a BMI > 35, major esophageal motility disorders, or concomitant hiatal hernia repair. We performed propensity score matching (1:1) and controlled for age, sex, race, ethnicity, diaphragmatic hernia, and proton pump inhibitor (PPI) use. Primary outcomes included postoperative PPI recidivism (excluding the first 3 months), post-TIF esophagitis, and need for subsequent foregut surgery. Secondary outcomes included post-TIF dysphagia, gas bloat symptoms, and 30-day complications. RESULTS: After propensity matching, 112 non-obese and 112 class I obese patients were included with similar baseline characteristics. Median follow-up exceeded 1,000 days in both groups. Postoperative PPI recidivism, esophagitis, surgical interventions, dysphagia and complications were similar. Notably, bloating was significantly lower in the obese group at 1 year (aOR 0.420; 95% CI 0.18-0.95) and maximum follow-up (aOR 0.446; 95% CI 0.21-0.97). CONCLUSIONS: TIF appears safe and effective for GERD in adults with class I obesity with comparable outcomes to non-obese patients.
引用
- Jaber F, Adames SM, Jaber M, et al. Efficacy and safety of transoral incisionless fundoplication in non-obese and obese adults: a population-based cohort study from the United States. Surg Endosc. 2026. PMID: 42390805. doi:10.1007/s00464-026-13084-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。